[ET Net News Agency, 27 March 2026] EVEREST MED (01952) rose 10.7% to HK$38.4.
It hits an intra-day high of HK$38.48, breaking above the 50-D SMA of HK$37.772, and an intra-day low of HK$34.26. The total shares traded was 3.79 million, with a value of HK$140.84m. The active buy/sell ratio is 66:34, with net buying turnover of HK$41.75m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$8.47m, with volume weighted average price of HK$37.367. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$15.39m, with volume weighted average price of HK$37.301.
Basic Information| Nominal | 38.400 | % Chg | +10.73% |
| High | 38.480 | Low | 34.260 |
| Shares Tr | 3.79m | Turnover | 140.84m |
| 10-D SMA | 35.564 | %H.V | 65.738 |
| 20-D SMA | 35.738 | VWAP | 37.119 |
| 50-D SMA | 37.772 | RSI14 | 55.249 |
Status: Breaking above the 50-D SMA, active buy/sell ratio is 66:34, with net buying turnover of HK$41.75m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| EVEREST MED (01952) | 38.40 | +10.73 |
| INNOVENT BIO (01801) | 84.80 | +6.80 |
| XTALPI (02228) | 9.42 | +1.62 |
| WUXI BIO (02269) | 32.46 | +2.92 |
| WUXI APPTEC (02359) | 114.80 | +1.32 |
| CSTONE PHARMA-B (02616) | 8.08 | +17.10 |
| BEONE MEDICINES (06160) | 172.40 | +5.06 |
| DUALITYBIO-B (09606) | 269.40 | +5.23 |
| AKESO (09926) | 122.70 | -0.81 |
| REMEGEN (09995) | 90.85 | +2.54 |
(ed)
Nominal 